AUTLAutolus Therapeutics plc
$1.77+18% 1Y
$1.77
$1.2152 weeks$2.54
The financials
Autolus Therapeutics plc by the numbers
Autolus Therapeutics plc (AUTL) reported revenue of $46M in Q2 2026 (quarter ended Jun 30, 2026), up 118% from the same quarter a year earlier. That came with a gross margin of 55% and net loss of $39M. For the full year FY2025, revenue was $75M (+645% year on year) and net income −$288M. The next results filing is expected around Nov 11, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $46M | $21M | +118% |
| Gross profit | $25M | −$3.5M | to a profit |
| Operating income | −$44M | −$61M | n/a |
| Net income | −$39M | −$48M | n/a |
| Diluted EPS | −$0.15 | −$0.18 | n/a |